Heme biosynthetic pathway in erythroid cells and the role of ATP-binding cassette transporter B7 (ABCB7 gene): The first enzyme of heme synthesis is 5-aminolevulinate synthase (ALAS2), which is the rate-limiting enzyme
Heme biosynthetic pathway in erythroid cells and the role of ATP-binding cassette transporter B7 (ABCB7 gene): The first enzyme of heme synthesis is 5-aminolevulinate synthase (ALAS2), which is the rate-limiting enzyme. In the presence of pyridoxal phosphate, it condenses glycine and succinyl-coenzyme to form ALA. Mutations in the erythroid-specific ALAS2 gene cause X-linked sideroblastic anemia (XLSA) by impairing the synthesis of delta-aminolevulinic acid (ALA). ALA is transported out of the mitochondria into the cytosol to continue the heme synthesis. Ultimately, heme synthesis involves the incorporation of ferrous iron into protoporphyrinogen. However, hereditary sideroblastic anemia can affect genes that encode proteins involved in the synthesis, trafficking, or incorporation of iron–sulfur clusters, such as ALAS2, HSPA9, SLC25A38, GLRX5, or ABCB7. In particular, ABCB7 is crucial for hematopoiesis and is located at Xp13.3. The ABCB7 gene encodes a mitochondrial transporter of the Fe–S cluster. These clusters are initially synthesized as Fe-S intermediates within the mitochondria and subsequently transported to the cytoplasm for maturation15 by the mitochondrial transporter ABCB7. ABCB7 mutations cause a rare recessive X-linked sideroblastic anemia with ataxia (XLSA/A) disorder